Bassi Giada, Rossi Arianna, Campodoni Elisabetta, Sandri Monica, Sarogni Patrizia, Fulle Stefania, Voliani Valerio, Panseri Silvia, Montesi Monica
Institute of Science, Technology and Sustainability for Ceramics, National Research Council of Italy, via Granarolo n. 64, Faenza, Ravenna (RA) 48018, Italy.
Department of Neuroscience, Imaging and Clinical Science, University of Studies "G. D'Annunzio", via dei Vestini n. 31, Chieti, Chieti (CH) 66100, Italy.
ACS Appl Mater Interfaces. 2024 Oct 1;16(41):55011-26. doi: 10.1021/acsami.4c02567.
Osteosarcoma, among all bone sarcomas, remains a challenge despite the unwavering efforts of medical professionals and scientists. To address this, the scientific community is actively pursuing the development of three-dimensional (3D) models to faithfully replicate the heterogeneity of osteosarcoma, thereby facilitating the reliable preclinical screening of potential therapies. In this study, we present the latest advancements in engineering an 3D osteosarcoma model comprising enriched Cancer Stem Cells (CSCs) and a hybrid hydroxyapatite-based scaffold (MgHA/CoII). The improvement of the model occurred through two primary steps: (1) serial passaging of sarcospheres as the CSCs enrichment system and (2) the optimization of the structural configuration of the niche in the scaffold. Two injection-mediated approaches of sarcosphere seeding were designed and extensively characterized and Chorioallantoic Membrane (CAM) models to explore their biological properties and tumorigenic potential. The combination of the selected enriched-CSCs and custom-made seeding into the scaffold resulted in the development of 3D osteosarcoma models exhibiting tumor-like features and tumorigenic properties . The outcomes of this study offer prospects for future endeavors involving more complex systems capable of replicating specific malignant tumor behaviors (metastatic process and drug resistance), pushing the discovery of new therapeutic strategies for clinical applications.
在所有骨肉瘤中,尽管医学专业人员和科学家们不懈努力,但骨肉瘤仍然是一个挑战。为了解决这一问题,科学界正在积极致力于开发三维(3D)模型,以忠实地复制骨肉瘤的异质性,从而便于对潜在疗法进行可靠的临床前筛选。在本研究中,我们展示了构建一种包含富集癌干细胞(CSCs)和基于羟基磷灰石的混合支架(MgHA/CoII)的3D骨肉瘤模型的最新进展。该模型的改进通过两个主要步骤实现:(1)将球形瘤体进行连续传代作为CSCs富集系统,以及(2)优化支架中微环境的结构配置。设计并广泛表征了两种注射介导的球形瘤体接种方法,并利用鸡胚绒毛尿囊膜(CAM)模型来探索它们的生物学特性和致瘤潜力。将选定的富集CSCs与定制接种到支架中的方法相结合,成功构建出了具有肿瘤样特征和致瘤特性的3D骨肉瘤模型。本研究结果为未来涉及能够复制特定恶性肿瘤行为(转移过程和耐药性)的更复杂系统的研究提供了前景,推动了临床应用新治疗策略的发现。